MATERIAL EVENT4579.TTSE

RaQualia Pharma: change in major shareholder

Summary

RaQualia Pharma Inc. filed an extraordinary report via EDINET on 2025-04-18 15:30 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100VN2M ↗ · PDL1.0 · Not investment advice